Alterity Therapeutics Ltd
ATHE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131343
In the last 90 days, Alterity Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $2.12M in total; no superinvestor holds it.
Other share classesPRNAF
Q2 2026 vs. Q1 2026
How the institutions holding Alterity Therapeutics Ltd changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 15 | 21 | +6 |
| Shares | 320.8K | 394.5K | +73.6K (+23.0%) |
| Value | $1.12M | $2.12M | +$999.7K (+89.4%) |
New holders (6)
Institutions that held Alterity Therapeutics Ltd at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 17,292 | $92.0K | 0.00% |
| Providence Capital Advisors, LLC | 200 | $1.07K | 0.00% |
| UBS Group AG | 5 | $27 | 0.00% |
| Cranbrook Wealth Management, LLC | 1 | $6 | 0.00% |
| Citigroup Inc | 1 | $5 | 0.00% |
| Caitong International Asset Management Co., Ltd | 1 | $5 | 0.00% |
Sold out (0)
Institutions that held Alterity Therapeutics Ltd at the end of Q1 2026 and filed for Q2 2026 without it.
None.